Business / Finance

RSS

Armetheon raises $7 million in first round of financing

Armetheon, Inc., a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing.

28 Aug 2014

Report on Co-development Terms & Agreements in Pharma, Biotech and Diagnostics

The Co-development Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies.

28 Aug 2014

Nepstar's Q2 2014 revenue increases by 7.5% to RMB686.6 million (US$110.7 million)

China Nepstar Chain Drugstore Ltd., a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2014.

28 Aug 2014

Americana announces strategic partnership with COMS Interactive

Americana Corporation is pleased to announce a strategic partnership with COMS Interactive, LLC (Clinical Outcomes Management Systems or COMS). The partnership supports an interface between Americana Corporation's AmeraCare products/services and the COMS Daylight IQ™ disease management software.

26 Aug 2014

Leading European IT company invests $3 million in LogicNets

LogicNets, Inc., the web-based Expert Decision Support platform used for automating complex decision-making processes, announces an investment of $3 million from ICT Automatisering (Euronext: ICT:NA), a leading European IT services company headquartered in the Netherlands.

25 Aug 2014

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform.

25 Aug 2014

Aldea Pharmaceuticals announces closure of $24M Series B equity financing

Aldea Pharmaceuticals, a company pioneering novel therapeutics to treat aldehyde metabolism disorders, today announced that it has closed a $24 million Series B equity financing.

25 Aug 2014

ESAOTE launches MyLab™Six at European Society of Cardiology 2014

Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab™Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC (European Society of Cardiology, Barcelona, 30th August - 3rd September). Configured for an extensive range of applications, MyLab™Six delivers a premium quality, yet affordable, solution for shared ultrasound services across any busy clinical setting.

24 Aug 2014

ESAOTE launches MyLab™Gamma at European Society of Cardiology 2014

Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable “green” ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote’s productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment’s notice.

24 Aug 2014

Biorem Q2 2014 revenues up 25%

BIOREM Inc. today announced results for the three month and six month periods ended June 30, 2014.

23 Aug 2014

Thermal Tennis, CannaSys sign merger agreement

Thermal Tennis, Inc., a Nevada corporation that focuses on the development of tennis management and training programs announced today that it has entered into an agreement and plan of merger (the "Merger Agreement") with CannaSys, Inc., a Colorado corporation that provides innovative marketing solutions for the growing medical and recreational cannabis industry.

22 Aug 2014

CARE Oklahoma partners with COMS Interactive

The Coalition of Advocates for Responsible Eldercare (CARE Oklahoma) has announced their newest CARE Partnership with COMS Interactive, LLC (also known as Clinical Outcomes Management Systems or COMS).

22 Aug 2014

NeuroDerm signs definitive investment agreements for $16 million financing round

NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group.

21 Aug 2014

US Fitness adds Sport & Health to its portfolio of clubs

US Fitness Holdings, LLC announced today it has added Sport & Health to its portfolio of clubs, creating one of the largest health club companies in the country.

21 Aug 2014

Avizia announces closing of equity financing round

Avizia, Inc., a leading provider of cutting-edge telemedicine solutions, today announced that it has closed an equity financing round led by NextGen Angels along with Blu Venture Investors and Middleland Capital.

19 Aug 2014

Cardiva Medical closes private equity financing and senior secured facility with GE Capital

Cardiva Medical, Inc. announced today that it has closed the first two tranches of a $16.5 million Series 3 private equity financing and a $12.5 million senior secured facility with GE Capital.

19 Aug 2014

Genesis HealthCare signs definitive agreement to merge with Skilled Healthcare Group

Genesis HealthCare, one of the nation's largest providers of post-acute care services, today announced that it has signed a definitive agreement to combine with Skilled Healthcare Group, Inc., based in Foothill Ranch, California.

19 Aug 2014

Novartis and Gamida Cell sign Option and Investment Agreements

Elbit Imaging Ltd. announced today that Elbit Medical Technologies Ltd., a subsidiary of the Company in which it holds approximately 86% of the voting power, announced that on August 18, 2014, Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power and a vast majority of Gamida Cell's shareholders (including Elbit Medical), signed Option and Investment Agreements with Novartis Pharma AG (Novartis).

19 Aug 2014

ASAHI INTECC, Boston Scientific to develop new, differentiated FFR wire

Boston Scientific Corporation and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire.

19 Aug 2014